Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Frequently asked questions
What sector does Thor Medical ASA (TRMED) operate in?
Thor Medical ASA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Thor Medical ASA (TRMED) current stock price?
As of the latest data, Thor Medical ASA stock price is NOK 4.16, with a previous close of NOK 4.20. Thor Medical ASA lost -NOK 0.05 in the last trading session, representing a -1.07% loss.
What is Thor Medical ASA (TRMED) current market capitalization?
Thor Medical ASA market cap is approximately 1.76 billion.
What is Thor Medical ASA (TRMED) Earnings Per Share (EPS)?
The trailing EPS is -NOK 0.23, and the forward EPS is -NOK 0.06.
Does Thor Medical ASA (TRMED) pay dividends?
No. Thor Medical ASA does not pay a dividend.
When is Thor Medical ASA (TRMED) next earnings report?
Thor Medical ASA is expected to release its next earnings report on December 31, 2026.
What is Thor Medical ASA (TRMED) beta (volatility) score?
Thor Medical ASA has a beta of -0.012, indicating lower volatility than the overall market.